Omega Diagnostics on the rise again

A look at some of the major movers in London on Friday

Arcontech Group PLC -

Omega Diagnostics Group PLC (LON:ODX) jumped 13% to 92.25p following the publication of a report by Ulster University on the Abc-19 COVID-19 lateral flow antibody test.

The test, which has been developed by the UK Rapid Test Consortium, was tested against the Roche and Abbott immunoassays to detect SARS-CoV2 antibodies, alongside the EuroImmun IgG SARS-CoV-2 ELISA, across a large cohort of plasma samples from Northern Ireland.

Using a ‘pseudo gold standard’ the authors of the report concluded that the UK-RTC AbC-19 lateral flow immunoassay shows a sensitivity of 97.70% and specificity of 100%.

2.25pm: Empyrean Energy appoints joint broker; what usually comes next?

Empyrean Energy PLC (LON:EME) shares eased 6.5% to 3.95p after the company appointed First Equity Limited as its joint broker.

The share price reaction is unlikely to be a verdict on Cenkos; it is more likely that investors suspect that the new broker may be coming on board to help an equity issue get away.

1.20pm: Wincanton canters higher after resilient trading performance

Wincanton Plc (LON:WIN), the logistics company, motored 10p (4.7%) higher to 222p after it said trading remains “resilient”.

The Digital and eFulfilment business continues to benefit from increased demand for online retail, while performance and the level of new business wins across the rest of the group has been encouraging.

It’s barely more than three weeks since the company raised full-year guidance so it is not surprising it has left that guidance unchanged.

12.15pm: OptiBiotix indirectly buoyed by FDA authorisation

OptiBiotix Health PLC (LON:OPTI) was up 4.6% at 57.5p on news of an investigational new drug authorisation.

A drug development firm has been given the green light to take into human trials a treatment for irritable bowel syndrome (IBS) that contains OptiBiotix’s Lactobacillus Plantarum LPLDL probiotic.

The company said Seed Health’s investigational new drug application has been approved by the US Food & Drug Administration, which will allow DS-01 to go straight into phase II clinical trials.

11.10am: Pires Investments rises after update on portfolio company

Pires Investments PLC (LON:PIRI) advanced 6.7% to 4.8p after a company in which it has a stake announced a new product related to coronavirus COVID-19.

Pires has a 13.3% interest in Sure Valley Ventures (SVV), a venture capital fund focused on investing in the software technology sector with a specific focus on artificial intelligence, the internet of things and immersive technologies.

SVV itself has within its investment portfolio a company called Ambisense, which has launched a product called AmbiAir, which manages, assesses and predicts the COVID-19 risk in commercial and public buildings.

10.05am: Centamin lowers guidance

Centamin PLC (LON:CEY) lost 18% of its value at 164.6p after it reduced production guidance for the current year.

The change was occasioned by ground movement, which forced an area of the Sukari gold mine to be shut down. The movement was in a localised area of waste material in the Sukari open-pit Stage 4 West wall, the gold miner said in a statement.

Open-pit mining operations in this zone have been halted as a preventative safety measure, Centamin added.

9.00am: Arcontech jumps after bagging new client

Arcontech Group PLC (LON:ARC) surged 13% to 167p after the real-time financial market data specialist announced a new client win.

The fintech firm has signed a new Tier 1 bank client for its Multi-Vendor Contribution System, which enables parties to provide information to numerous outlets simultaneously.

The bank will use the system to provide real-time prices to data aggregator Factset.

Cruises operator Carnival PLC (LON:CCL) was sitting low in the water, down 3% at 940.8p, after it flagged up an imminent business update.

The company has scheduled a conference call with analysts for Thursday, October 8.

Yesterday afternoon, the operator of “floating Petri dishes” said its Carnival Cruise Line business had cancelled cruises from all US home ports except Miami and Port Canaveral for November and December 2020.

Proactive news headlines

Cobra Biologics will manufacture Scancell Holdings PLC’s (LON:SCLP) COVID-19 vaccine ready for a phase I clinical trial. The agreement covers the good manufacturing practice (GMP) production of plasmid DNA needed to generate the inoculation against SARS-CoV-2.

A drug development firm has been given the green light to take into human trials a treatment for irritable bowel syndrome (IBS) that contains OptiBiotix Health PLC's (LON:OPTI) Lactobacillus Plantarum LPLDL probiotic. The company said Seed Health’s investigational new drug application has been approved by the US Food & Drug Administration, which will allow DS-01 to go straight into phase II clinical trials.

One Media IP Group PLC (LON:OMIP) has now paid the final US$100,000 of the fee for the acquisition of the music catalogue of Philip Wesley. The digital music rights acquirer, publisher and distributor acquired the catalogue of the American composer and solo piano artist a year ago but part of the payment was deferred, as it was dependent on how well the deal panned out.

Falcon Oil & Gas Ltd (LON:FOG) told investors that an 11-stage hydraulic stimulation programme has been completed at part of the Beetaloo shale project in Australia’s Northern Territory. The 11 stages were carried out along the well’s 1,579-metre horizontal section in the Lower Kyalla formation.

Bezant Resources PLC (LON:BZT), the copper-gold exploration and development company, said exploration work has started at the Hope Copper-Gold Project, Namibia. This first phase of work by Bezant will focus on exploration licence EPL5796 hosting the Hope and Gorob-Vendome massive sulphide deposits, part of a combined indicated and inferred mineral resource within three closely spaced deposits of 10.2mln tonnes @ 1.9% Cu (copper) and 0.3 grams per tonne (g/t) Au (gold) at a 0.7% Cu cut-off.

Bahamas Petroleum Company PLC (LON:BPC) has updated investors on licence administration in Trinidad. The company has agreed with state-backed Heritage Petroleum the three-month extension of the contract to December 31 to give Heritage time to obtain requisite consents from the Ministry of Energy and Energy Industries for the implementation of a new 10-year Enhanced Production Sharing Contract (EPSC) agreement.

Westminster Group PLC (LON:WSG) has been notified by holders of its convertible loan notes that they have elected to convert £93,750-worth into 937,500 ordinary shares. This latest conversion further reduces the outstanding CLN amount to £1.5mln with a corresponding reduction in interest charges, the company said.

Brunner Investment Trust PLC PLC (LON:BUT) confirmed that its top 10 shareholdings continues to be led by Microsoft Corp, UnitedHealth Group and Roche Holding AG. 

Metal Tiger PLC (LON:MTR) said its board has approved the adoption of a new share option incentive scheme for key staff and management. In addition, the company has extended the exercise period in respect of certain existing options. "The company considers that the award of options linked to the performance of the company are critical to the incentivisation of its key staff and management and to ensure that there is alignment between management and shareholders," it said.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


AEX Gold say 'significant potential for expanding the resource base at Nalunaq'

AEX Gold Inc's (LON:AEX) (CVE:AEX), Eldur Olafsson speaks to Proactive London's Katie Pilbeam about the latest results at their flagship Nalunaq property in South Greenland. Olaffsson says that infill drilling at Nalunaq successfully intercepted the Main Vein with true thicknesses of up to...

1 hour, 44 minutes ago

6 min read